Cite
HARVARD Citation
Van Wyk, J. et al. (2020). Switching to DTG/3TC fixed-dose combination (FDC) Is non-inferior to continuing a TAF-based regimen in maintaining virologic suppression through 48 weeks (TANGO Study). Journal of infection and public health. 13 (2), pp. 349-. [Online].